Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Regarding illegal shorting awhile ago someone on this BB suggested investors protect their shares from being used in this manner. They indicated placing a sell order on their entire position at a very high sell price to take the shares off of the playing field. I’m curious how many investors are using this strategy.
As always thank you Lykiri for your DD! That is great news for all the patients who need this product on the market. Thank you for changing my bad mood into a happy dancing mood! I’ve been dealing with bureaucracy in the health care insurance system most of this afternoon. While it kept me distracted from the days trading it was a fruitless and frustrating endeavor. It was so refreshing to check in with the BB to read such great news! Thanks again!
Margaret
With this study please keep in mind it was based on 8 BP companies. Not completely apples to apples but helpful information as to possible timelines for NWBO.
Pump here are the SEC regulations regarding legal NDA financing:
https://www.sec.gov/Archives/edgar/data/822418/000119312513047319/d476767dex99d2.htm
How are you “sure” about at least 1 week?
Revised number of employees under search for Advent on LinkedIn (31) as follows:
CFO New York
GMP Production Scientist Greater Cambridge Area
3 GMP Production Scientist London
GMP Production Scientist Cambridge, England
Sr GMP Production Scientist London, England
GMP Quality Control Scientist UK
Head of Quality Assurance Great Shelford, England
Head of Quality Control Peterborough
Quality Manager Greater Cambridge Area
COO Greater Cambridge Area
Office Manager Greater Cambridge Area
Quality Control Scientist London
QA Assistant London
Facilities Manager Greater Cambridge Area
Head of IT Stevenage, England
Trainee Production Scientist United Kingdom
Validation Lead Hitchin, England
Process Development Manager Dartford, England
ATMP Scientist Barnet, England
Trainee Production Scientist Milton Keynes, England
Finance Supervisor Sawston, England
Quality Control Scientist Royston, England
Human Resource Manager Cambridge, England
Warehouse Manager Little Paxton, England
Facilities Coordinator Cambridge, England
Laboratory System Admin Great Shelford, England
QA Officer Great Shelford, England
Mfg Lab Assistant Crick, England
Laboratory Technician Stevenage, England
Unknown Greater Cambridge Area
My apologies. My original LinkedIn search was broader than I thought. Go NWBO and their partners!!!
I decided on a dark afternoon to peruse LinkedIn. I found 53 professionals when I searched under Advent Bioservices. Forty-nine appear to be currently employed worldwide, not just in the UK. I do not have access to info on each person other than if they've posted a picture and their title at Advent Bioservices. I cannot vouch for the accuracy of any of the employees as I do not know any of them personally. I am thankful that I have an understanding husband that knows why I jumped on NWBO's BB on a Sunday. Go NWBO!
I hope everyone had a relaxing weekend!
Take care,
Margaret
The closing price yesterday on E*Trade was .7747. GLTA Longs!
Thanks for posting NWBO model of statistical significance video. That was very informative.
Yesterday I picked up 10K shares not 1K but thanks for the support on lowering my pps.
Exactly! I’m not going to haggle over pennies with upcoming TLD. I can’t wait for $8.75 and beyond. GLTL’s. Why is it pertinent to post share holdings on reddit and not here? Just curious.
Great job! I did that yesterday morning too. Surprised someone by buying on the ask.
Why .875? You post this number almost everyday...show charts or something as to justify your posting this guess. I’ll start guessing 8.75 is still in play and be just as believable.
How about reading my post before commenting? My post had absolutely nothing to do with management of NWBO.
My car is in the Atlanta area I however am in the PNW and won't be at that race.
I would no more call myself a professional driver or call Linda to tell her how to run a Biotech company. I'd take driving courses from my business partner Ed and how to run a Biotech company courses from Linda Powers if she is still a professor teaching exactly that.
The car is based out of the Atlanta area. Nascar is adding in more road courses so there is a driver development need for the oval racers.
If you are speaking about my car, this is my car without NWBO. I will add additional race cars if NWBO does as well as expected. GLTL’s
That’s awesome! Do you drive TransAm 2? The landscape is changing and the team I work with assists already licensed drivers learn and win on road courses not just turning left.
Thanks everyone for the support of my race car investment! I am not the one to give my opinion on racing motors as I don’t know much about racing, in all this fun I am a race car rental company. I saw a win win business opportunity and jumped at the chance. Not in my wildest dreams did I believe I’d be doing this 6 months ago. Vroom vroom NWBO and my Stang!
What will you do with your NWBO profits? Here is my current hobby! I'll be adding to my collection of Mustangs not driving them! (Anyone want to learn how to be a race car driver?). More dreams in the making while we wait for TLD and beyond. My guess is we'll have TLD right before SNO and publication announcement on Wednesday before SNO. This is 100% a guess as we wait for more news. Good luck to all, goodnight and good morning wherever you are in the world.
Guess who now is a proud owner of a race car! ME?!? PM me if you, your business or anyone you know is interested in the driver development or product marketing/sponsorship of my new baby for the 2022 race season!
Reminder of upcoming accolades: Dr Liau’s induction ceremony into the Asian Hall of Fame on November 13, 2021.
https://www.asianhalloffame.org/
Just a reminder: AJMC Presentation Cancer Treatments, Orphan Drugs, Gene Therapies Represent Big Areas to Watch in Specialty Drug Pipeline
October 20, 2021
Skylar Jeremias.
https://www.ajmc.com/view/cancer-treatments-orphan-drugs-gene-therapies-represent-big-areas-to-watch-in-specialty-drug-pipeline
47% of the current specialty drug pipeline for approval at the FDA are orphan drugs. Interesting read for me as I wait for not just TLD. GLTL
Margaret
Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs
October 23, 2020
Christina Mattina
https://www.ajmc.com/view/areas-to-watch-in-specialty-drug-pipeline-include-cancer-orphan-drugs
An ongoing trend is the increase in drugs approved to treat cancer, as 16 have been approved so far this year and 5 more are expected to be approved by the end of the year, which would break the record of 17 cancer drug approvals set in 2018. Orphan drugs make up a majority of the specialty pipeline, representing the extensive interest in orphan drug development.
Redneck - My apology my last post was a stand alone comment, not a reply.
AJMC Presentation Cancer Treatments, Orphan Drugs, Gene Therapies Represent Big Areas to Watch in Specialty Drug Pipeline
October 20, 2021
Skylar Jeremias.
https://www.ajmc.com/view/cancer-treatments-orphan-drugs-gene-therapies-represent-big-areas-to-watch-in-specialty-drug-pipeline
47% of the current specialty drug pipeline for approval at the FDA are orphan drugs. Interesting read for me as I wait for not just TLD. GLTL
Margaret
Thanks for sharing what assisted you in learning to chart. I look forward to getting a better grasp on charting.
Thanks pgsd for the MHRA link!
Thx - I was looking for MHRA certification information and I stumbled on this in the meantime. I still did a happy dance when I found it!
MHRA timelines
https://www.gmmh.nhs.uk/download.cfm?doc=docm93jijm4n2766.pdf&ver=4500
4.5. MHRA Review
Valid Clinical Trial Applications are assessed within 30 days of the receipt.
MHRA must provide a response within a total of 60 days from receipt of the original application (except for trials involving medicinal products for gene therapy, somatic cell therapy or medicinal products containing genetically modified organisms where the timeframe is 90 days). If further information is requested this should be sent to the MHRA within 14 days of the request so not to affect the 60 day timeline. All correspondence will be sent to the person named in Section C of the Clinical Trial Application form (i.e. the Chief Investigator (CI) or Sponsor’s representative) and should be filed on Q-Pulse (the Trial Master File) by the R&I Office.
pgsd - Thx for the 10q and 10k info. Does pgsd stand for Puget Sound by chance? GLTU
With Covid timeframes I’ve waited longer for mail, longer on holds with businesses I’ve called, and Covid has caused multitudes of disruptions in every business sector of the world. My question is why would anyone not expect that Covid impacted NWBO’s timeframes in the last 2 years? I realize they had other reasons for the start/stop last year, I’m just wondering if Covid impacted NWBO’s current timeframe since there are a lot of people and moving parts going on outside of their control.
Soj,
I wanted to thank you for your charting and insight. I appreciate your knowledge and sharing your perspective with this board on a consistent basis even in the face of criticism.
Hi Survivor,
I am relatively new in comparison to most who post on this board. I have known about NWBO for a year and a half and been invested for a little over a year now. I am continuing to add NWBO to my portfolio at this time. This is a higher risk than I normally invest in but I believe in the science and will continue to add to my position until TLD.
Advent Job Postings:
HTTPS://adventbio.peoplehr.net/jobboard/